Infant Flow™ SiPAP

For over two decades, the Infant Flow™ nCPAP system has delivered gentle respiratory support to thousands of neonates worldwide. The system, combined with the patented variable flow generator, provides NPPV by offering nasal CPAP, Biphasic and Biphasic tr modalities. The system takes the work out of breathing, freeing precious calories to be used for growth and development.

The American Academy of Pediatrics and the European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome each recommend the early use of continuous positive airway pressure (CPAP). [5,6]

Features & Benefits

  • Lowest work of breathing [1]
  • Decrease the need of intubation by 78% [2]
  • 40% less days on respiratory support in patients treated with BiPhasic mode [3]
  • 47% of neonates required less oxygen compared to conventional nCPAP [3]
  • Compliant with U.S. National Patient Safety Goal (NPSG 06.01.01) for alarm safety [4]

Customer Education Resources

Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.

The Latest News From Vyaire

Vyaire Statement on imtmedical ag / Hamilton Patent Dispute

On June 17, 2020, the Swiss Supreme Court denied an appeal brought by imtmedical ag regarding a long-standing Swiss patent dispute concerning certain flow sensor types.

Read More
Vyaire Signs Framework Contract with European Commission for Delivery of Ventilators in Response to COVID-19 Pandemic

CHICAGO – May 14, 2020 – Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, announced today that Vyaire has been selected by the European Commission as a supplier of priority medical equipment to help address the COVID-19 pandemic.

Read More

Contact a Sales Representative